How the BOND trial will test prenatal mental health support for congenital heart disease
The BOND trial will test HeartGPS and breastfeeding support for families affected by critical congenital heart disease across 17 US centers.
Pharma & Biotech
Pharma & Biotech
Emalex Biosciences advances Tourette syndrome strategy as ecopipam delays relapse in Phase 3 trial
D1 receptor targeting may change Tourette syndrome care. Ecopipam’s Phase 3 data now face the bigger test: regulation and adoption.
Pharma & Biotech
Replacing microbiota rejuvenates aging gut tissue: What new mouse data means for regenerative GI therapies
A mouse study suggests young microbiota can rejuvenate aging gut tissue. Find out what this could mean for regenerative GI therapies and IBD care.